VASER Liposuction may Improve Diabetes in Overweight patients
It has been of significant interest whether liposuction may have an effect on diabetes in overweight patients. A prospective study was recently performed showing that VASER liposuction may have a potential beneficial effect on diabetes.
- Overweight male patients aged 37.15 ± 9.60 years (6 with diabetes type 2, 11 without comorbidities) and 10 age-matched healthy lean controls were enrolled in the study.
- Using Vibration Amplification of Sound Energy at Resonance System (VASER Liposuction), ultrasound assisted liposuction was applied onto the deep layers of abdominal subcutaneous adipose tissue. The mean volume supranatant fat was 2208 ± 562 ml.
- Fasting blood was collected on the day of liposuction, within 1 to 2 months and more than 6 months after surgery.
- Both treatment groups (diabetic and nondiabetic patients) experienced similar postsurgical weight reduction with concomitant lowering of body mass index value at 1 to 2 months follow-up, which was sustained after 6 months from surgery.
- Improvement in insulin sensitivity at 1 to 2 months follow-up was observed (p = .017 and p = .002, for diabetics and nondiabetics, respectively) and this change persisted over the next 4 months.
With this study, VASER liposuction of the abdomen may have beneficial effects in overweight diabetic and non-diabetic males by improving their insulin sensitivity.
Gibas-Dorna, et al. The Effect of VASER Abdominal Liposuction on Metabolic Profile in Overweight Males. Am J Mens Health. 2016 Oct 18. pii: 1557988316674841.